ArticleHeliyon2024

Synergistic effects of the combination of trametinib and alpelisib in anaplastic thyroid cancer with BRAF and PI3KCA co-mutations.

Chiao-Ping Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.